TSPAN32 and neoplasm: We sought to determine whether TSPAN32 is differentially expressed in leukemic versus healthy hematopoietic cells, to identify potential transcriptional networks that modulate its expression, and to assess its potential role as a tumor suppressor or modulatory factor within the leukemic transcriptional landscape.